Search Results 21-30 of 15938 for SC

  1. A Study of the Safety of Joint Injected Sc-rAAV2.5IL-1Ra (a Virus Carried Gene Therapy) in Patients with Moderate Knee Osteoarthritis - Mayo Clinic

    The purpose of this study is to determine the safety of sc-rAAV2.5IL-1Ra, a gene therapy carried by a virus and delivered by injection into the knee joint of ...

  2. Publications - Stephanie C. Mavis, M.D., M.H.P.E. - Mayo Clinic

    Annankra WB, Fang JL, Yao NA, Mavis SC. Answering the call for decolonizing global health education: a qualitative approach to educational needs assessment ...

  3. Carolinas Hospital System joins Mayo Clinic Care Network

    FLORENCE, S.C. – Carolinas Hospital System and Mayo Clinic announced today that Carolinas Hospital System has joined the Mayo Clinic Care Network, a growing ...

  4. Michael Camilleri, M.D. - Doctors and Medical Staff - Mayo Clinic

    Awards and honors · 2012. Distinguished Mentor AwardAmerican Gastroenterological Association · 2007. Research Career Achievement AwardDepartment of Internal ...

  5. A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis - Mayo Clinic

    Clinical Trials · A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants ...

  6. Mayo Clinic

    Mayo Clinic is the No. 1 hospital in the world., with campuses in Arizona, Florida, and Minnesota.

  7. Publications - Salvatore C. Lettieri, M.D. - Mayo Clinic

    Taggart CM, Pieri PG, Gridley DG, Chundu K, Jamshidi R, Lettieri SC, Feiz-Erfan I. Posterior cervical-thoracic spinal fixation using mandibular ...

  8. Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients with Dumping Syndrome - Mayo Clinic

    Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in ...

  9. Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple Myeloma

    Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple ...

  10. Octreotide (injection route, intramuscular route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Octreotide injection is used to treat severe diarrhea and other symptoms that occur with certain intestinal tumors (eg, vasoactive intestinal peptide tumors or ...